Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-01-12

Clinical Trial Update: L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain [NA]

View source ↗

Summary

A clinical trial evaluating L-menthol as a topical counter-irritant to TRPA1-induced neurogenic inflammation and pain has completed. The study targeted inflamma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-menthol (L-menthol)

Snippet

Sponsor: Aalborg University | Conditions: Inflammation, Pruritus | NA | Status: COMPLETED